$607.14
12.642.13%
At Close: -
$607.14
00.00%
After Hours: 4:05 PM EDT
15 minutes delayed
Comments
Loading...
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Thermo Fisher Scientific (NYSE:TMO) Stock, Analyst Ratings, Price Targets, Forecasts
Thermo Fisher Scientific Inc has a consensus price target of $625.23 based on the ratings of 25 analysts. The high is $711 issued by Cowen & Co. on February 2, 2023. The low is $520 issued by Wells Fargo on July 28, 2023. The 3 most-recent analyst ratings were released by TD Cowen, Raymond James, and RBC Capital on July 25, 2024, respectively. With an average price target of $660.67 between TD Cowen, Raymond James, and RBC Capital, there's an implied 8.82% upside for Thermo Fisher Scientific Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
TD Cowen
Raymond James
RBC Capital
Stifel
Baird
1calculated from analyst ratings
Analyst Ratings for Thermo Fisher Scientific
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/25/2024 | Buy Now | 8.38% | TD Cowen | Dan Brennan | $648 → $658 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | 8.71% | Raymond James | Andrew Cooper | $650 → $660 | Maintains | Outperform | Get Alert |
| 07/25/2024 | Buy Now | 9.37% | RBC Capital | Conor McNamara | $660 → $664 | Maintains | Outperform | Get Alert |
| 07/25/2024 | Buy Now | 1.29% | Stifel | Daniel Arias | $600 → $615 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | 4.09% | Baird | Catherine Schulte | $620 → $632 | Maintains | Outperform | Get Alert |
| 07/02/2024 | Buy Now | -1.18% | Evercore ISI Group | Vijay Kumar | $615 → $600 | Maintains | Outperform | Get Alert |
| 06/28/2024 | Buy Now | -1.18% | Barclays | Luke Sergott | $615 → $600 | Maintains | Equal-Weight | Get Alert |
| 06/03/2024 | Buy Now | 7.06% | Jefferies | Tycho Peterson | $600 → $650 | Assumes | Hold → Buy | Get Alert |
| 04/30/2024 | Buy Now | 10.35% | HSBC | Rajesh Kumar | $660 → $670 | Maintains | Buy | Get Alert |
| 04/25/2024 | Buy Now | 7.06% | JP Morgan | Rachel Vatnsdal | $600 → $650 | Maintains | Overweight | Get Alert |
| 04/25/2024 | Buy Now | 1.29% | Barclays | Luke Sergott | $590 → $615 | Maintains | Equal-Weight | Get Alert |
| 04/25/2024 | Buy Now | 0.47% | Deutsche Bank | Justin Bowers | $600 → $610 | Maintains | Buy | Get Alert |
| 04/25/2024 | Buy Now | 2.12% | Baird | Catherine Schulte | $621 → $620 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | 8.71% | HSBC | Rajesh Kumar | $630 → $660 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 5.41% | Goldman Sachs | Matthew Sykes | $550 → $640 | Maintains | Buy | Get Alert |
| 04/04/2024 | Buy Now | 0.47% | Evercore ISI Group | Vijay Kumar | $575 → $610 | Maintains | Outperform | Get Alert |
| 03/18/2024 | Buy Now | 2.12% | Citigroup | Patrick Donnelly | → $620 | Reinstates | → Neutral | Get Alert |
| 02/01/2024 | Buy Now | 5.74% | RBC Capital | Conor McNamara | $592 → $642 | Maintains | Outperform | Get Alert |
| 02/01/2024 | Buy Now | -0.35% | Raymond James | Andrew Cooper | $515 → $605 | Maintains | Outperform | Get Alert |
| 01/24/2024 | Buy Now | -8.59% | Barclays | Luke Sergott | $475 → $555 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/08/2024 | Buy Now | — | Bernstein | Eve Burstein | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/18/2023 | Buy Now | 0.47% | HSBC | Rajesh Kumar | → $610 | Initiates | → Buy | Get Alert |
| 12/14/2023 | Buy Now | 10.35% | Baird | Catherine Schulte | → $670 | Maintains | Outperform | Get Alert |
| 12/13/2023 | Buy Now | — | Wolfe Research | Doug Schenkel | — | Initiates | → Outperform | Get Alert |
| 12/11/2023 | Buy Now | -5.29% | Citigroup | Patrick Donnelly | $530 → $575 | Maintains | Buy | Get Alert |
| 11/06/2023 | Buy Now | -9.41% | Argus Research | David Toung | $540 → $550 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | -13.69% | Baird | Catherine Schulte | $589 → $524 | Maintains | Outperform | Get Alert |
| 10/26/2023 | Buy Now | -21.76% | Barclays | Luke Sergott | $585 → $475 | Maintains | Overweight | Get Alert |
| 10/26/2023 | Buy Now | -12.71% | Stifel | Daniel Arias | $660 → $530 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | -4.63% | RBC Capital | Conor McNamara | $657 → $579 | Maintains | Outperform | Get Alert |
| 10/26/2023 | Buy Now | -12.71% | Citigroup | Patrick Donnelly | $625 → $530 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | -15.18% | Raymond James | Andrew Cooper | $580 → $515 | Maintains | Outperform | Get Alert |
| 10/26/2023 | Buy Now | -10.23% | Morgan Stanley | Tejas Savant | $600 → $545 | Maintains | Overweight | Get Alert |
| 10/26/2023 | Buy Now | — | Keybanc | Paul Knight | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 10/25/2023 | Buy Now | -17.65% | Goldman Sachs | Matthew Sykes | → $500 | Maintains | Buy | Get Alert |
| 10/25/2023 | Buy Now | -5.29% | B of A Securities | Derik De Bruin | → $575 | Maintains | Buy | Get Alert |
| 10/24/2023 | Buy Now | -1.18% | Morgan Stanley | Tejas Savant | $640 → $600 | Maintains | Overweight | Get Alert |
| 10/23/2023 | Buy Now | -2.99% | Baird | Catherine Schulte | $625 → $589 | Maintains | Outperform | Get Alert |
| 10/18/2023 | Buy Now | -4.47% | Raymond James | Andrew Cooper | $630 → $580 | Maintains | Outperform | Get Alert |
| 10/17/2023 | Buy Now | 3.77% | JP Morgan | Rachel Vatnsdal | $670 → $630 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | 8.21% | RBC Capital | Conor McNamara | $685 → $657 | Maintains | Outperform | Get Alert |
| 10/16/2023 | Buy Now | 4.59% | B of A Securities | Derik De Bruin | $635 → $635 | Maintains | Buy | Get Alert |
| 10/12/2023 | Buy Now | -2.82% | Deutsche Bank | Justin Bowers | $620 → $590 | Maintains | Buy | Get Alert |
| 10/02/2023 | Buy Now | 2.94% | Citigroup | Patrick Donnelly | $625 → $625 | Reiterates | Buy → Buy | Get Alert |
| 09/29/2023 | Buy Now | -3.65% | Barclays | Luke Sergott | $625 → $585 | Maintains | Overweight | Get Alert |
| 09/28/2023 | Buy Now | -0.68% | Bernstein | Eve Burstein | → $603 | Initiates | → Outperform | Get Alert |
| 09/06/2023 | Buy Now | 2.94% | Citigroup | Patrick Donnelly | → $625 | Reinstates | Buy → Buy | Get Alert |
| 08/27/2023 | Buy Now | 12.82% | RBC Capital | Conor McNamara | → $685 | Maintains | Outperform | Get Alert |
| 08/23/2023 | Buy Now | 4.59% | B of A Securities | Derik De Bruin | $635 → $635 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | -14.35% | Wells Fargo | Timothy Daley | $505 → $520 | Maintains | Underweight | Get Alert |
| 07/28/2023 | Buy Now | 3.77% | Raymond James | Andrew Cooper | $595 → $630 | Maintains | Outperform | Get Alert |
| 07/27/2023 | Buy Now | 10.35% | JP Morgan | Rachel Vatnsdal | $660 → $670 | Maintains | Overweight | Get Alert |
| 07/27/2023 | Buy Now | 8.71% | Stifel | Daniel Arias | $700 → $660 | Maintains | Buy | Get Alert |
| 07/27/2023 | Buy Now | 5.41% | Morgan Stanley | Tejas Savant | $620 → $640 | Maintains | Overweight | Get Alert |
| 07/27/2023 | Buy Now | 14.97% | RBC Capital | Conor McNamara | $662 → $698 | Maintains | Outperform | Get Alert |
| 07/27/2023 | Buy Now | 2.94% | Baird | Catherine Schulte | $664 → $625 | Maintains | Outperform | Get Alert |
| 07/27/2023 | Buy Now | 2.94% | Barclays | Luke Sergott | $590 → $625 | Maintains | Overweight | Get Alert |
| 07/26/2023 | Buy Now | 4.59% | B of A Securities | Derik De Bruin | → $635 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | 9.37% | Baird | Catherine Schulte | $670 → $664 | Maintains | Outperform | Get Alert |
| 07/13/2023 | Buy Now | 2.12% | Credit Suisse | Dan Leonard | → $620 | Upgrade | Neutral → Outperform | Get Alert |
| 07/10/2023 | Buy Now | -2.82% | Barclays | Luke Sergott | $610 → $590 | Maintains | Overweight | Get Alert |
| 07/06/2023 | Buy Now | 7.06% | B of A Securities | Derik De Bruin | $650 → $650 | Maintains | Buy | Get Alert |
| 07/06/2023 | Buy Now | 3.77% | SVB Leerink | Puneet Souda | $630 → $630 | Maintains | Outperform | Get Alert |
| 06/06/2023 | Buy Now | 7.06% | B of A Securities | Derik De Bruin | $650 → $650 | Maintains | Buy | Get Alert |
| 05/25/2023 | Buy Now | 8.71% | JP Morgan | Rachel Vatnsdal | $675 → $660 | Maintains | Overweight | Get Alert |
| 05/25/2023 | Buy Now | 5.41% | Keybanc | Paul Knight | $710 → $640 | Maintains | Overweight | Get Alert |
| 05/24/2023 | Buy Now | 7.06% | B of A Securities | Derik De Bruin | $650 → $650 | Maintains | Buy | Get Alert |
| 05/24/2023 | Buy Now | 10.35% | Baird | Catherine Schulte | $670 → $670 | Maintains | Outperform | Get Alert |
| 05/10/2023 | Buy Now | 7.06% | B of A Securities | Derik De Bruin | $650 → $650 | Maintains | Buy | Get Alert |
| 04/27/2023 | Buy Now | 3.77% | SVB Leerink | Puneet Souda | $630 → $630 | Maintains | Outperform | Get Alert |
| 04/27/2023 | Buy Now | 7.06% | Citigroup | Patrick Donnelly | $700 → $650 | Maintains | Buy | Get Alert |
| 04/27/2023 | Buy Now | 9.04% | RBC Capital | Conor McNamara | $664 → $662 | Maintains | Outperform | Get Alert |
| 04/27/2023 | Buy Now | 2.12% | Morgan Stanley | Tejas Savant | $670 → $620 | Maintains | Overweight | Get Alert |
| 04/27/2023 | Buy Now | 14.14% | TD Cowen | Dan Brennan | $711 → $693 | Maintains | Outperform | Get Alert |
| 04/27/2023 | Buy Now | 10.35% | Baird | Catherine Schulte | $693 → $670 | Maintains | Outperform | Get Alert |
| 04/27/2023 | Buy Now | 0.47% | Barclays | Luke Sergott | $625 → $610 | Maintains | Overweight | Get Alert |
| 04/12/2023 | Buy Now | 9.37% | RBC Capital | Conor McNamara | → $664 | Maintains | Outperform | Get Alert |
| 04/04/2023 | Buy Now | 0.47% | Evercore ISI Group | Vijay Kumar | $615 → $610 | Maintains | Outperform | Get Alert |
| 04/04/2023 | Buy Now | 2.94% | Barclays | Luke Sergott | $660 → $625 | Maintains | Overweight | Get Alert |
| 02/03/2023 | Buy Now | 15.29% | Stifel | Daniel Arias | → $700 | Maintains | Buy | Get Alert |
| 02/02/2023 | Buy Now | 11.18% | JP Morgan | Rachel Vatnsdal | $650 → $675 | Maintains | Overweight | Get Alert |
| 02/02/2023 | Buy Now | 7.88% | RBC Capital | Conor McNamara | → $655 | Maintains | Outperform | Get Alert |
| 02/02/2023 | Buy Now | 17.11% | Cowen & Co. | Dan Brennan | $690 → $711 | Maintains | Outperform | Get Alert |
| 02/02/2023 | Buy Now | 15.29% | Citigroup | Patrick Donnelly | $650 → $700 | Maintains | Buy | Get Alert |
| 02/02/2023 | Buy Now | 10.35% | Morgan Stanley | Daniel Brennan | $613 → $670 | Maintains | Overweight | Get Alert |
| 02/02/2023 | Buy Now | 8.71% | Barclays | Luke Sergott | $630 → $660 | Maintains | Overweight | Get Alert |
| 02/02/2023 | Buy Now | 3.77% | SVB Leerink | Puneet Souda | $620 → $630 | Maintains | Outperform | Get Alert |
| 02/01/2023 | Buy Now | 1.29% | Evercore ISI Group | Vijay Kumar | $590 → $615 | Maintains | Outperform | Get Alert |
| 02/01/2023 | Buy Now | 7.06% | B of A Securities | Derik De Bruin | $650 → $650 | Maintains | Buy | Get Alert |
| 02/01/2023 | Buy Now | 16.94% | Baird | Catherine Schulte | $665 → $710 | Maintains | Outperform | Get Alert |
| 01/30/2023 | Buy Now | 7.39% | RBC Capital | Conor McNamara | → $652 | Maintains | Outperform | Get Alert |
| 01/24/2023 | Buy Now | 3.77% | Barclays | Luke Sergott | $570 → $630 | Maintains | Overweight | Get Alert |
| 01/20/2023 | Buy Now | 7.06% | B of A Securities | Derik De Bruin | $600 → $650 | Maintains | Buy | Get Alert |
| 01/06/2023 | Buy Now | 2.12% | SVB Leerink | Puneet Souda | $555 → $620 | Maintains | Outperform | Get Alert |
| 01/03/2023 | Buy Now | -16.82% | Wells Fargo | Timothy Daley | $525 → $505 | Maintains | Underweight | Get Alert |
| 12/14/2022 | Buy Now | 2.12% | Deutsche Bank | Justin Bowers | → $620 | Initiates | → Buy | Get Alert |
| 12/07/2022 | Buy Now | 8.87% | RBC Capital | Conor McNamara | → $661 | Initiates | → Outperform | Get Alert |
| 11/29/2022 | Buy Now | -6.12% | Barclays | Luke Sergott | $575 → $570 | Maintains | Overweight | Get Alert |
| 11/01/2022 | Buy Now | 9.53% | Baird | Catherine Ramsey | $695 → $665 | Maintains | Outperform | Get Alert |
| 10/30/2022 | Buy Now | 2.12% | Stifel | Daniel Arias | → $620 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Thermo Fisher Scientific (TMO) stock?
The latest price target for Thermo Fisher Scientific (NYSE:TMO) was reported by TD Cowen on July 25, 2024. The analyst firm set a price target for $658.00 expecting TMO to rise to within 12 months (a possible 8.38% upside). 51 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Thermo Fisher Scientific (TMO)?
The latest analyst rating for Thermo Fisher Scientific (NYSE:TMO) was provided by TD Cowen, and Thermo Fisher Scientific maintained their buy rating.
When was the last upgrade for Thermo Fisher Scientific (TMO)?
The last upgrade for Thermo Fisher Scientific Inc happened on July 13, 2023 when Credit Suisse raised their price target to $620. Credit Suisse previously had a neutral for Thermo Fisher Scientific Inc.
When was the last downgrade for Thermo Fisher Scientific (TMO)?
The last downgrade for Thermo Fisher Scientific Inc happened on January 24, 2024 when Barclays changed their price target from $475 to $555 for Thermo Fisher Scientific Inc.
When is the next analyst rating going to be posted or updated for Thermo Fisher Scientific (TMO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Thermo Fisher Scientific, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Thermo Fisher Scientific was filed on July 25, 2024 so you should expect the next rating to be made available sometime around July 25, 2025.
Is the Analyst Rating Thermo Fisher Scientific (TMO) correct?
While ratings are subjective and will change, the latest Thermo Fisher Scientific (TMO) rating was a maintained with a price target of $648.00 to $658.00. The current price Thermo Fisher Scientific (TMO) is trading at is $607.14, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.